Use of Digital Health Technologies in Clinical Investigations to Support Drug and Biological Product Development (U01) Clinical Trials Optional
Agency: Food and Drug Administration
- 93.103 -- Food and Drug Administration Research
Archived opportunityLast Updated: Jul 20, 2026
Important dates
- Archived: September 19, 2026
- Closed: August 20, 2026
Award details
- Expected project funding: Not specified
- Expected awards: 2
Award min.
$0
Award max.
$1,100,000
- Funding opportunity number:RFA-FD-26-012
- Cost sharing or matching requirement:No
- Funding instrument type:
- Cooperative agreement
- Opportunity Category:Discretionary
- Opportunity Category Explanation:Not specified
- Category of Funding Activity:
- Agriculture
- Consumer protection
- Food and nutrition
- Category Explanation:Not specified
History
- Posted date: July 20, 2026
- Archive date: September 19, 2026
- Version: 1
Summary
Jump to documentsThe purpose of this Notice of Funding Opportunity (NOFO) is to address topics related to the use of digital health technologies (DHTs) for remote data acquisition in clinical investigations to support drug development.
Eligibility
Government
- City or township governments
- Federally recognized Native American tribal governments
- Special district governments
- Public and Indian housing authorities
- County governments
- State governments
Business
- For-profit organizations other than small businesses
- Small businesses
Education
- Independent school districts
- Public and state institutions of higher education
- Private institutions of higher education
Nonprofit
- Nonprofits non-higher education with 501(c)(3)
- Other Native American tribal organizations
- Nonprofits non-higher education without 501(c)(3)
Additional information on eligibility
Documents
| File name | Description | Last updated |
|---|---|---|
| RFA-FD-26-012.pdf | Full Notice of Funding Opportunity Announcement | Jul 23, 2026 07:45 PM UTC |
Link to additional information
No additional information is available
